Low-carb diet may improve beta-cell function in type 2 diabetes patients

This study shows a carbohydrate-restricted diet boosts β-cell function in type 2 diabetes, offering a sustainable approach to manage the disease effectively.

Biogen, GSK, Novo Nordisk and five other biopharmas land on annual list of best inventions for 2023

It’s been a busy year of new drug discoveries, and today a handful of pharma companies were singled out for their work. Biogen, Eisai, GSK,

October 25, 2023

All the new drugs approved in 2023: Alzheimer’s and gene therapy cap a five-year high

After kicking off 2023 with a potential megablockbuster in Eisai and Biogen’s new Alzheimer’s drug Leqembi, in totality the FDA signed off on 10 more

January 4, 2024

Groundbreaking study reveals most effective adjunctive drug for Parkinson’s disease

The efficacy, tolerability, and safety of various anti-Parkinson’s drugs.

October 23, 2023

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.